A strategy to design protein-based antagonists against type I cytokine receptors.

Saved in:
Bibliographic Details
Title: A strategy to design protein-based antagonists against type I cytokine receptors.
Authors: Ullrich T; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany., Klimenkova O; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Pollmann C; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany., Lasram A; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany., Hatskovska V; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Maksymenko K; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany., Milijaš-Jotić M; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany., Schenk L; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Lengerke C; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Hartmann MD; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany., Piehler J; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany., Skokowa J; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., ElGamacy M; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.
Source: PLoS biology [PLoS Biol] 2024 Nov 26; Vol. 22 (11), pp. e3002883. Date of Electronic Publication: 2024 Nov 26 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39591631
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A strategy to design protein-based antagonists against type I cytokine receptors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ullrich+T%22">Ullrich T</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Klimenkova+O%22">Klimenkova O</searchLink>; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Pollmann+C%22">Pollmann C</searchLink>; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.<br /><searchLink fieldCode="AU" term="%22Lasram+A%22">Lasram A</searchLink>; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.<br /><searchLink fieldCode="AU" term="%22Hatskovska+V%22">Hatskovska V</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Maksymenko+K%22">Maksymenko K</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Milijaš-Jotić+M%22">Milijaš-Jotić M</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schenk+L%22">Schenk L</searchLink>; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lengerke+C%22">Lengerke C</searchLink>; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+MD%22">Hartmann MD</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Piehler+J%22">Piehler J</searchLink>; Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.<br /><searchLink fieldCode="AU" term="%22Skokowa+J%22">Skokowa J</searchLink>; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22ElGamacy+M%22">ElGamacy M</searchLink>; Max Planck Institute for Biology, Department of Protein Evolution, Tübingen, Germany.; Translational Oncology, Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101183755%22">PLoS biology</searchLink> [PLoS Biol] 2024 Nov 26; Vol. 22 (11), pp. e3002883. <i>Date of Electronic Publication: </i>2024 Nov 26 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101183755 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1545-7885 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215449173%22">15449173 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Biol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39591631
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pbio.3002883
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e3002883
    Titles:
      – TitleFull: A strategy to design protein-based antagonists against type I cytokine receptors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ullrich T
      – PersonEntity:
          Name:
            NameFull: Klimenkova O
      – PersonEntity:
          Name:
            NameFull: Pollmann C
      – PersonEntity:
          Name:
            NameFull: Lasram A
      – PersonEntity:
          Name:
            NameFull: Hatskovska V
      – PersonEntity:
          Name:
            NameFull: Maksymenko K
      – PersonEntity:
          Name:
            NameFull: Milijaš-Jotić M
      – PersonEntity:
          Name:
            NameFull: Schenk L
      – PersonEntity:
          Name:
            NameFull: Lengerke C
      – PersonEntity:
          Name:
            NameFull: Hartmann MD
      – PersonEntity:
          Name:
            NameFull: Piehler J
      – PersonEntity:
          Name:
            NameFull: Skokowa J
      – PersonEntity:
          Name:
            NameFull: ElGamacy M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 11
              Text: 2024 Nov 26
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1545-7885
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: PLoS biology
              Type: main
ResultId 1